Moving xenotransplantation from bench to bedside: Managing infectious risk.

Nellore, Anoma; Walker, Jeremey; Kahn, Mauricio J; Fishman, Jay A

Nellore, Anoma; Walker, Jeremey; Kahn, Mauricio J; Fishman, Jay A.

Afiliación

Nellore A; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Walker J; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Kahn MJ; Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Fishman JA; Division of Infectious Diseases and Transplant Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Transpl Infect Dis ; 24(6): e13909, 2022 Dec.

Article en En | MEDLINE | ID: mdl-35870125

Asunto(s)

Infecciones; Neoplasias; Animales; Humanos; Porcinos; Trasplante Heterólogo/efectos adversos; Infecciones/etiología; Terapia de Inmunosupresión/efectos adversos; Huésped Inmunocomprometido; Neoplasias/complicaciones

Palabras clave

CRISPR; designated pathogen free; immunosuppression; infection control; porcine cytomegalovirus; xenografts

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones / Neoplasias Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Transpl Infect Dis Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google